An Open-Label Pilot Study Evaluating by Magnetic Resonance Imaging the Potential for a Disease-Modifying Effect of Celecoxib Compared to a Modelized Historical Control Cohort in the Treatment of Knee Osteoarthritis
To access this article, please choose from the options below
J.P. Raynauld is a consultant for ArthroVision Inc. J. Martel-Pelletier and J.P. Pelletier are consultants for and holders of stocks in ArthroLab Inc. and ArthroVision Inc. A. Beaulieu, L. Bessette, F. Morin, D. Choquette, and B. Haraoui received honoraria from ArthroLab Inc. F. Abram is an employee of ArthroVision Inc.
PII: S0049-0172(09)00145-0
doi:10.1016/j.semarthrit.2009.10.003
© 2010 Elsevier Inc. All rights reserved.
